glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1 Receptor Agonists | New

doi: 10.1080/10408398.2021.1951155 45 Borka BalasRMelitLELupuALupuVVMargineanCO

doi: 10.7150/thno.58655 41 DasguptaSPutluriNLongWZhangBWangJKaushikAKet al

The timing and spacing of these compounds matters because both affect digestive processes and hepatic metabolism, potentially creating absorption conflicts if taken simultaneously

doi: 10.1158/0008-5472.CAN-06-0484

PubMed Randomized trialTirzepatide evidence2022 Tirzepatide Once Weekly for the Treatment of Obesity Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability

P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., Hartman, M